Food, Drug & Agriculture

Bladder Cancer Drug Padcev is Linked to Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) in 2021   (Posted by Tom Lamb at Drug Injury Watch)   Padcev (enfortumab vedotin-ejfv), an injection drug for intravenous use, was approved by the FDA in December 2019 for the treatment of certain adult patients with locally advanced or metastatic urothelial cancer (mUC), a type of bladder cancer. It is important for patients and their families to know…